一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Advanced Science >>article
Advanced Science

Advanced Science

IF: 14.3
Download PDF

G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC‐I via PI3K/Akt Activation in Bladder Cancer

Published:12 December 2023 DOI: 10.1002/advs.202305922
Xianchong Zheng, Jiawei Chen, Minhua Deng, Kang Ning, Yulu Peng, Zhenhua Liu, Xiangdong Li, Zhaohui Zhou, Huancheng Tang, Yaoying Li, Tiebang Kang, Zhuowei Liu

Abstract

Immune checkpoint inhibitors (ICIs) show promise as second-line treatment for advanced bladder cancer (BLCA); however, their responsiveness is limited by the immune evasion mechanisms in tumor cells. This study conduct a Cox regression analysis to screen mRNA-binding proteins and reveals an association between Ras GTPase-activating protein-binding protein 1 (G3BP1) and diminished effectiveness of ICI therapy in patients with advanced BLCA. Subsequent investigation demonstrates that G3BP1 enhances immune evasion in BLCA cells by downregulating major histocompatibility complex class I (MHC-I) through phosphoinositide 3-kinase (PI3K)/Akt signaling activation. Mechanistically, G3BP1 interacts with splicing factor synergistic lethal with U5 snRNA 7 (SLU7) to form a complex with poly(A)-binding protein cytoplasmic 1 and eukaryotic translation initiation factor 4 gamma 1. This complex stabilizes the closed-loop structure of the mRNAs of class IA PI3Ks and consequently facilitates their translation and stabilization, thereby activating PI3K/Akt signaling to downregulate MHC-I. Consistently, targeting G3BP1 with epigallocatechin gallate (EGCG) impedes immune evasion and sensitizes BLCA cells to anti-programmed cell death (PD)-1 antibodies in mice. Thus, G3BP1 and SLU7 collaboratively contribute to immune evasion in BLCA, indicating that EGCG is a precision therapeutic agent to enhance the effectiveness of anti-PD-1 therapy.

Substances (4)

Materials
Procduct Name CAS Molecular Formula Supplier Price
FLAG peptide 98849-88-8 C41H60N10O20 112 suppliers $32.00-$1000.00
FLAG peptide 98849-88-8 C41H60N10O20 112 suppliers $32.00-$1000.00
FLAG peptide 98849-88-8 C41H60N10O20 112 suppliers $32.00-$1000.00
FLAG peptide 98849-88-8 C41H60N10O20 112 suppliers $32.00-$1000.00

Similar articles

IF:5.7

The transdermal cream of Formestane anti-breast cancer by controlling PI3K-Akt pathway and the tumor immune microenvironment.

Frontiers in Immunology Lanyang Gao, Lei Zhu,etc Published: 1 January 2023
IF:4.4

ACVR1 mediates renal tubular EMT in kidney fibrosis via AKT activation

Cellular signalling Tianli Yu, Zhangyu Mai,etc Published: 23 November 2024
IF:3.2

PKN2 Promotes Peripheral Nerve Repair by Regulating Autophagy via Activation of the AKT‐mTOR Pathway: An In Vitro Study

Journal of Biochemical and Molecular Toxicology Lin Wang, Yuan‐sheng Huang,etc Published: 22 November 2024
南丹县| 泰兴市| 菏泽市| 巫山县| 丹凤县| 光山县| 壶关县| 大兴区| 崇信县| 平泉县| 苍溪县| 健康| 渭源县| 太康县| 都匀市| 南开区| 巨野县| 衡东县| 沈丘县| 应城市| 土默特右旗| 通许县| 新丰县| 鄂尔多斯市| 马公市| 辛集市| 禄丰县| 宿州市| 台东市| 南江县| 永寿县| 蒲江县| 元谋县| 水富县| 甘孜| 蒙阴县| 安陆市| 鹤峰县| 温泉县| 耒阳市| 泸溪县|